NATIONAL DOCUMENTATION CENTRE Athens, 18 December 2002 HELLENIC KICK-OFF EVENT

1. NATIONAL DOCUMENTATION CENTRE Athens, 18 December 2002 HELLENIC KICK-OFF EVENT 6th Framework Programme Maria Theofilatou

2. Framework Programme (2002-2006)

3. Framework Programme 6 (2002-2006) Focus on strategic areas where immediate and longer term integration of European research is needed to generate and sustain necessary critical mass New instruments- integrated projects networks of excellence

4. Overall architecture of the 6th FP

5. Sixth Framework Programme Thematic priorities: € 11285 M M € 1.1.1 Life sciences, genomics and biotechnology for health 2255 1.1.2. Information society technologies 3625 1.1.3. Nanotechnologies and nano-sciences, knowledge- based multifunctional materials & processes 1300 1.1.4. Aeronautics and space 1075 1.1.5. Food quality and safety 685 1.1.6. Sustainable development, global change and ecosystems 2120 1.1.7. Citizens and governance in a knowledge-based society 225

6. 1.1 Advanced genomics and its application for health Thematic priority 1: Life sciences, genomics and biotechnology for health (€ 1100 M) • 1.1.a Fundamental knowledge and basic tools for functional genomics in all organisms • 1.1.b Applications of knowledge and technologies in the field of genomics and biotechnology for health 1.2 Combating major diseases (€ 1155 M) • 1.2.a Application oriented genomic approaches to • medical knowledge and technologies • 1.2.b Combating cancer • 1.2.c Confronting the major communicable • diseases linked to poverty 755 M 400 M

7. Thematic priority 1: Life sciences, genomics and biotechnology for health Advanced genomics and its application for health (1100 M € ) Fundamental Genomics Biotechnology

8. Gene expression and proteomics Structural genomics Comparative genomics and population genetics Bioinformatics Multidisciplinary functional genomics approaches to basic biological processes 1.1.a. Fundamental knowledge and basic tools for functional genomics in all organisms 110001ATC1010010101010011011AUG01101010010101101010101010TTC110101001001000CCG

9. Thematic priority 1: Life sciences, genomics and biotechnology for health Combating major diseases (1155 M € ) Medical knowledge & technologies Cancer Poverty-related diseases

10. SMEs Academia Ethical Bodies Clinicians DELIVERABLES FOR SOCIETY RESEARCH DEVELOPMENT REGULATION Regions Private Sector European Investment Bank Civil Society Parliament Member States Commission Success will depend on mobilisation of all actors

11. From 2000 EoI to one Workprogramme • Where do the topics in our workprogramme come from? • Submitted EoIs • Gaps identified by experts • Commission’s Strategy to foster ERA • None of the topics reproduce exactly one EoI: • Combination of several EoIs • Addition of elements • Modification of scope A balance between Focusing  Ensuring Competition

12. Invitation for Expressions of Interest An opportunity for Europe’s research community to help prepare for the first calls of FP6 • Consultation to the scientific community on its readiness to implement new instruments in the 7 priority themes of 6FP • The results have helped to define the Work Programmes and to prepare the 6FP calls • It has facilitated the understanding by the research community of the potential of the new instruments

13. Expressions of Interest Result WholeFP6:  Some 13.000 EoIs received and evaluated Priority one:  Close to 2.000 EoIs received  Evaluated with the help of over 200 external experts  2/3 Integrated Projects and 1/3 Networks

14. Close to 2000 EoI !!! Expressions of Interest Results

15. Priority One Implementation • 53 topics published in the first call • Total budget for first call: EUR 513 million, • broken down as follows: • InstrumentEUR (millions)Integrated project or network of excellence 385 – 410 • Specific targeted research project or • co-ordination action 92 – 121 • Specific support actions 8 – 10

16. Priority One Implementation 15% of FP budget is for participation of small and medium sized enterprises (SMEs)

17. Priority One Implementation • Ethics: • Research with human beings • Research with animals • Stem cells • Biological materials or data atribuable to individuals • Clinical Trials • EDCTP • Pediatrics New in FP6

18. Call for proposals Evaluation by a strengthened peer-review system involving individual reviews, remote evaluation, panel sessions, hearings of applicants… Specific criteria will include: scientific quality potential impact on strengthening Europe’s excellence excellence of the network members extent, depth and lasting nature of the integration contribution to spreading excellence management and governance of the network Evaluation process

19. www.cordis.lu/life/src/projects.htm Thematic priority 1: Life sciences, genomics and biotechnology for health How to find partners? Former EU-funded projects including partner information can be found on: FP6 Partners Database:www.cordis.lu/fp6/partners.htm EoI:eoi.cordis.lu/search_form.cfm

20. More information Help-Desk Life Sciences, Genomics & Biotechnology for Health: rtd-genomics@cec.eu.int

21. Wider range Better differentiation New instruments Integrated projects (IP) Networks of excellence (NoE) Article 169 (joint implementation of national programmes) Instruments for implementing the thematic priorities (I)

22. Traditional instruments Specific targeted research projects Co-ordination actions Specific support actions Instruments for implementing the thematic priorities (II)

23. Simplification and streamlining to minimise the overheads for all concerned whether applicant, contractor or the Commission to speed up procedures, especially time-to-contract Flexibility and adaptability to enable instruments to be applicable throughout the priority themes to enable projects to evolve Principles guiding their design (I)

24. Increased management autonomy to eliminate unnecessary micro-management While preserving public accountability and protecting interests of the Community Principles guiding their design (II)

25. Classification of the instruments

26. Calls for proposals will identify which instruments are to be used, which have priority, and for what From the outset, IPs and NoE will be the priority means for implementing those themes where it is already deemed appropriate while maintaining the use of specific targeted research projects and coordination actions Instruments to be used in priority (I)

27. In 2004, the Commission will arrange an independent evaluation of the use of the instruments may lead to an adjustment of their relative weightings Instruments to be used in priority (II)

28. “FP6 Integrated Projects”

29. Designed to generate the knowledge required to implement the priority thematic areas of FP6 by integrating the critical mass of activities and resources needed to achieve ambitious,clearly defined scientific and technologicalobjectives Essentially an instrument for supporting objective-driven research of a European dimension Purpose of Integrated Projects (I)

30. Activities integrated by a project may cover the full research spectrum should contain objective-driven research technological development and demonstration components as appropriate may contain a training component the effective management of knowledge will also be an essential feature the whole carried out in a coherent management framework Activities

31. Maximum rates of support for FC and FCF participants: 50% for RTD and innovation-related components 35% for any demonstration component 100% for any training activities 100% for consortium management AC participants: supported at up to 100% for all components of the project (except for consortium management which will be supported as under FCF) For IPs, no more than 7% of the Community contribution can be used to support consortium management costs reimbursed at up to 100% Rates of Community support

32. Concerning resources: each IP must assemble the critical mass of resources needed to achieve its ambitious objectives activities integrated may range up to several tens of million euro but no minimum threshold, provided necessary ambition and critical mass is achieved What is the scale of critical mass (I)?

33. Concerning the partnership: minimum of 3 participants from 3 different Member States or Associated States, of which at least 2 should be Member States or Associated candidate countries but in practice likely to be substantially more SME participation is strongly encouraged ‘third country’ participants may be included, with a possibility of Community financial support for entities from certain groups of countries What is the scale of critical mass (II)?

34. Concerning its duration: typically 3 to 5 years but more if necessary to deliver the objectives What is the scale of critical mass (III)?

35. Through calls for proposals may be preceded by expressions of interest to help focus calls and assist in consortium building Simplified proposal-making requiring only sufficient “management-level” detail reflecting evolutionary nature of the project summary description of activities for entire duration detailed implementation plan only for first 18 months Proposal submission (I)

36. For changes in the consortium the consortium may itself decide to take in new participants (though without additional funding) the contract will specify when this must involve a competitive call the Commission may decide to launch calls to add activities and participants (with additional funding) e.g. to enhance SME participation Flexibility and autonomy of implementation (II)

37. Robust monitoring of each IP by the Commission by one or possibly a team of project officers through annual review mid-term or milestone review (optional) final review involving external experts at all stages Monitoring

38. Regularly updated website on the instruments europa.eu.int/comm/research/fp6/networks-ip.html Brochures and leaflets on the new instruments (also available on Europa as above) Presentation slides (on Europa as above) Guide on “Participating in European Research” On integrated projects Leonidas.Karapiperis@cec.eu.int More Information on the instruments

39. “FP6 Networks of excellence” europa.eu.int/comm/research/nfp/networks-ip.html

40. NoE Objectives Strengthen Europe’s excellence on a particular research topic by integrating the critical mass of expertise needed to provide European leadership and be a world force around a joint programme of activities Tackling the fragmentation of European research where the main deliverable is a durable structuring and shaping of how research is carried out in Europe Spreading excellence beyond its partners

41. NoEThe joint programme of activities (1) A range of neworre-oriented activities: Integrating activities coordinated programming of the partners’ activities sharing of research platforms/tools/facilities joint management of the knowledge portfolio staff mobility and exchanges relocation of staff, teams, equipment reinforced electronic communication systems

42. NoEThe joint programme of activities (2) Joint research activities: a programme of joint research to support the network’s goals development of new research tools and platforms for common use generating new knowledge to fill gaps in or to extend the collective knowledge portfolio

43. NoEThe joint programme of activities (3) Activities to spread excellence training researchers and other key staff dissemination and communication activities networking activities to help transfer knowledge to trams external to the network where appropriate, promoting the exploitation of the results generated within the network where appropriate, innovation-related activities

44. NoEThe joint programme of activities (4) Network management overall coordination of the joint activities communication with the Commission, reporting activities linked to consortium-level financing and accounting management and legal issues coordination of the knowledge management activities, if appropriate, other innovation-related activities promotion of gender equality science and society issues supporting the governing board and other network bodies ALL ACTIVITIES WITHIN A COHERENT MANAGEMENT FRAMEWORK

45. NoEMeasuring integration(1) In their proposal, participants will include possible qualitative and quantitative indicators for measuring progress towards integration

46. NoEMeasuring integration(2) Main factors to be examined extent of mutual specialisation and mutual complementarity sharing /development for common use of research infrastructure, equipment, tools and platforms regular joint execution of research projects

47. NoEMeasuring integration(3) Main factors to be examined interactive working through electronic communication systems joint management of the knowledge portfolio joint training programme (researchers and other key staff) coherent management framework

48. NoECritical mass (1) Expertise: assembling of the critical mass needed to achieve the ambitious goals of the network variable from topic to topic larger networks may involve several hundreds of researchers may be smaller provided that the necessary ambition and critical mass are achieved

49. NoECritical mass (2) Partnership: in general at least six (legal minimum: 3 from 3 different countries) Duration of Community support:typically 5 years more if necessary BUT no more than 7 years

50. NoEFinancial regime (1) Community support targeted at overcoming the barriers to a durable integration these barriers are mainly organisational, cultural, human  cannot be quantified in normal accounting terms Has led to the concept of an incentive, taking the form of a global “fixed grant for integration”